RAFAEL
DELGADO VÁZQUEZ
Profesor titular de universidad
Instituto de Investigación Sanitaria Hospital 12 de Octubre
Madrid, EspañaPublikationen in Zusammenarbeit mit Forschern von Instituto de Investigación Sanitaria Hospital 12 de Octubre (10)
2023
-
Cell type dependent stability and virulence of a recombinant SARS-CoV-2, and engineering of a propagation deficient RNA replicon to analyze virus RNA synthesis
Frontiers in Cellular and Infection Microbiology, Vol. 13
-
Cross neutralization of SARS-CoV-2 omicron subvariants after repeated doses of COVID-19 mRNA vaccines
Journal of Medical Virology, Vol. 95, Núm. 1
-
Dendritic Cell-Mediated Cross-Priming by a Bispecific Neutralizing Antibody Boosts Cytotoxic T Cell Responses and Protects Mice against SARS-CoV-2
Advanced Science, Vol. 10, Núm. 34
-
Immune Response Against SARS-CoV-2 Infection and Vaccination in a CD8α-Deficient Patient
Journal of Clinical Immunology
-
N′-Phenylacetohydrazide Derivatives as Potent Ebola Virus Entry Inhibitors with an Improved Pharmacokinetic Profile
Journal of Medicinal Chemistry, Vol. 66, Núm. 8, pp. 5465-5483
-
Optimized vaccine candidate MVA-S(3P) fully protects against SARS-CoV-2 infection in hamsters
Frontiers in Immunology, Vol. 14
2022
-
Cellular and humoral immune responses and breakthrough infections after three SARS-CoV-2 mRNA vaccine doses
Frontiers in Immunology, Vol. 13
-
First confirmation of importation and transmission in Spain of the newly identified SARS-CoV-2 B.1.1.7 variant
Enfermedades Infecciosas y Microbiologia Clinica, Vol. 40, Núm. 10, pp. 546-549
-
Potent Neutralizing Activity of Polyclonal Equine Antibodies Against Severe Acute Respiratory Syndrome Coronavirus 2 Variants of Concern
The Journal of infectious diseases, Vol. 227, Núm. 1, pp. 35-39
2020
-
Prevalence and Clinical Manifestations of Congenital Cytomegalovirus Infection in a Screening Program in Madrid (PICCSA Study)
Pediatric Infectious Disease Journal, Vol. 39, Núm. 11, pp. 1050-1056